Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer.

Kim, Jongsu; Hwang, Kyung Won; Lee, Hye Jung; Kim, Hong Sook

Kim, Jongsu; Hwang, Kyung Won; Lee, Hye Jung; Kim, Hong Sook.

Afiliação

Kim J; Department of Biological Sciences, Sungkyunkwan University, Suwon 16419, Korea.
Hwang KW; Department of Biological Sciences, Sungkyunkwan University, Suwon 16419, Korea.
Lee HJ; Department of Biological Sciences, Sungkyunkwan University, Suwon 16419, Korea.
Kim HS; Department of Biological Sciences, Sungkyunkwan University, Suwon 16419, Korea.

J Pers Med ; 12(11)2022 Nov 02.

Article em En | MEDLINE | ID: mdl-36579559

Palavras-chave

ERG; SLC45A3; TCGA; drug repurposing; gene fusion; prostate cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pers Med Ano de publicação: 2022 Tipo de documento: Article